-17% Off

Mela B3 Dark Spot Serum With Melasyl™ + Niacinamide

Original price was: 4,800.00৳.Current price is: 4,000.00৳.

Born from 18 years of research.

This anti-aging serum visibly reduces a range of skin discoloration, including sunspots, age spots, post-acne marks (or post-inflammatory hyperpigmentation), and even the most persistent dark spots. Powered by Melasyl, the newest, exclusive La Roche-Posay ingredient, in combination with 10% Niacinamide. A first-of-its-kind discoloration treatment to visibly correct persistent dark spots with long-lasting results, while respecting the natural tone of all skin. Proven on all skin tones.*

Sign up here to try a Mela B3 Dark Spot Serum.

*Based on a 10 week study on 73 women of all skin phototypes

 

Skin Concern:

  • Discolorations
  • Dark spots
  • Age spots, sunspots, liver spots
  • Post-acne marks (Post-inflammatory hyperpigmentation)
  • Dull, uneven skin tone

Skin Type:

  • All skin types

Description

 

  • Visibly reduces a range of skin discolorations, including sunspots, age spots, post-acne marks (or post-inflammatory hyperpigmentation)
  • Helps visibly correct even persistent dark spots, while respecting skin’s natural tone

CLINICAL RESULTS

After 2 weeks of use:

  • Reveals brighter, more radiant skin
  • Skin imperfections look reduced*
  • Powerful, visibly lasting results – continues to maintain improvement

 

After 8 weeks of use:

  • 90% showed dark spot reduction**

 

When used in regimen of Mela B3 serum with Mela B3 UV:

  • Visible dark spot reduction
  • Improvement in skin brightness and skin texture
  • Improves skin plumpness

 

*Based on a consumer study of 73 women
**After 8 weeks of use 90% of subjects showed improvement in at least one of the size and contrast of a persistent dark spot or density of dark spots, as assessed by expert grading.

 

Reviews

There are no reviews yet.

Be the first to review “Mela B3 Dark Spot Serum With Melasyl™ + Niacinamide”

Your email address will not be published. Required fields are marked *